ArticleAnalytical and bioanalytical chemistry2026
Development of an aptamer-functionalized sorbent for the selective and specific extraction of lead from environmental and biological samples.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An oligonucleotide-based sorbent was developed to enable the selective extraction of lead ions from serum and water samples. Two oligonucleotide sequences, previously reported in the literature for their high affinity toward Pb(II), were grafted onto CNBr-activated Sepharose, producing sorbents suitable for solid-phase extraction. Grafting efficiencies ranged from approximately 50 to 70%. Subsequent optimization focused on adjusting the percolation and washing conditions to ensure preferential retention of Pb(II) on the specific aptamer-modified supports, followed by controlled elution. The elution kinetic was studied to minimize the elution volume. Under optimized conditions, high selectivity was obtained, with mean extraction recoveries of 83 ± 2.7% and 79 ± 8% (n = 3) for the specific sorbents, compared to only 7-10% for the control sorbents. Other cations showed recoveries below 15%, confirming the strong specificity of the developed sorbents. The capacity of the most efficient sorbent was estimated at approximately 600 ng per 30 mg of support (≈30 µg/g), which is suitable for the selective extraction of trace amounts of Pb(II) from serum or water samples. Applying this support to real samples made it possible to determine Pb(II) levels of 6.3 µg/L for tap water, 2.7 µg/L for the Seine River water, and 87 µg/L for digested serum samples, while reducing matrix effects and minimizing ICP-MS instrument clogging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.